Clinical Research

INFECTOPHARM Arzneimittel und Consilium GmbH

Address
Von-Humboldt-Strasse 1

Sponsor Overview

assignment
4
sponsored trials
science
4
molecules
location_city
45
research centres
public
1
country
person_search
44
investigators

Specializations

Parasitic skin infections

Research activity includes clinical work in scabies, with emphasis on topical treatment options for controlling infestation and relieving skin symptoms.

  • Scabies treatment
  • Permethrin-based therapy
  • Topical antiparasitic care

The sponsor’s trial portfolio in this area reflects interest in improving management of contagious ectoparasitic skin disease.

Atopic dermatitis prevention

Clinical research also focuses on early prevention of atopic dermatitis in infants with a high familial risk, using skin care approaches aimed at supporting the skin barrier.

  • Infant skin barrier support
  • Atopic dermatitis risk reduction
  • Moisturizing skin care

This area centers on childhood dermatology and the prevention of chronic inflammatory skin disease.

Actinic keratosis

The sponsor funds studies in actinic keratosis, addressing treatment options for mild to moderate precancerous skin lesions associated with chronic sun damage.

  • Keratinocyte lesion therapy
  • Topical lesion management
  • Solar-induced skin disease

These trials show a clear interest in non-invasive dermatologic treatment for premalignant skin conditions.

Sponsored Trials

Trial Name Country Status
Evaluation of Paraffin White Soft Cream for Prophylaxis of Atopic Dermatitis in High-Risk Pediatric Populations: A Randomized, Investigator-Blinded StudyGermany GermanyNot Recruiting
Phase III Randomized Double-Blind Study on Efficacy and Safety of 10% vs. 5% Permethrin Cream in Scabies TreatmentGermany GermanyRecruiting
Phase III/IV Multicenter Trial on Escalating Treatment of Scabies with Permethrin 5% and 10% Cream and Ivermectin TabletsGermany GermanyRecruiting
Randomized, Double-Blind Study on the Efficacy and Safety of 5% Potassium Hydroxide Solution Versus Placebo in Treating Mild to Moderate Actinic KeratosisGermany GermanyRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 4 total (25% not shared with other sponsors)

This sponsor works with 4 molecules, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
4%
Return partnership rate
2 of 45 sites collaborated multiple times

This sponsor has worked with 45 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Parasitic Diseases2 trials
    9 other sponsors
  • 2.
    Skin and Connective Tissue Diseases2 trials
    247 other sponsors

Partnered Research Centres

45 centres
location_city
assignment50
Barmherzige Brueder gemeinnuetzige Krankenhaus GmbH
Address
Pruefeninger Strasse 86, Westenviertel, 93049 Regensburg
Learn morearrow_forward
location_city
assignment10
CentroDerm GmbH
Address
Heinz-Fangman-Strasse 57, Barmen, 42287 Wuppertal
Learn morearrow_forward
location_city
assignment1047
Charite Universitaetsmedizin Berlin KöR
Address
Hindenburgdamm 30, Lichterfelde, 12203 Berlin
Learn morearrow_forward
location_city
assignment1
Dr. Nasserani MVZ GmbH
Address
Lünener Straße 211, 59174
Learn morearrow_forward
location_city
assignment1
Durani Cosmetics GmbH
Address
Grüne Meile 56, 69115 Heidelberg
Learn morearrow_forward
location_city
assignment34
Evangelisches Klinikum Bethel gGmbH
Address
Kantensiek 11, Gadderbaum, 33617 Bielefeld
Learn morearrow_forward
Page 1 of 8

Want to get in touch with this sponsor?

Send a question and we'll pass it on to INFECTOPHARM Arzneimittel und Consilium GmbH.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.